Next |
home / stock / moc / moc message board
Subject | By | Source | When |
---|---|---|---|
I hope this sale provides some additional contracts. | cj 13 | investorshub | 09/20/2018 1:04:35 AM |
* * $MOC Video Chart 08-02-18 * * | ClayTrader | investorshub | 08/02/2018 9:34:56 PM |
MOC share price looks like it's trying to | cj 13 | investorshub | 03/09/2018 3:12:29 PM |
29 percent year to year. Think the next | cj 13 | investorshub | 06/19/2017 5:50:21 PM |
I agree. I am definitely going to buy | Cboneofenglewood | investorshub | 06/18/2017 3:39:27 AM |
I am. Next two to three quarters Will | cj 13 | investorshub | 06/16/2017 1:44:57 AM |
I noticed that $MOC recently closed two contracts | Cboneofenglewood | investorshub | 06/15/2017 12:50:08 PM |
https://seekingalpha.com/article/4075631-command-security-new-contracts-pave-way | cj 13 | investorshub | 05/25/2017 9:50:55 PM |
There is the news we needed. 4mil float.. | cj 13 | investorshub | 05/02/2017 2:44:14 PM |
Hope this bounces off resistance of 2.5. | cj 13 | investorshub | 03/14/2017 12:34:08 AM |
Moc at least has been in a yearly | cj 13 | investorshub | 12/07/2016 3:45:06 PM |
I thought the stock spiked higher on that | hweb2 | investorshub | 11/29/2016 4:46:18 PM |
Why didn't the 10 year 1 billion dollar | cj 13 | investorshub | 11/29/2016 4:42:53 PM |
Saw today's PR. Not surprised the pop | hweb2 | investorshub | 11/29/2016 4:35:46 PM |
4 mil only float. New 50 mil | cj 13 | investorshub | 11/29/2016 4:26:02 PM |
G&T >>>>> 4.18 hod. | crudeoil24 | investorshub | 07/25/2016 1:39:25 PM |
$MOC bullish 3.01 | stocktrademan | investorshub | 07/15/2016 3:50:46 PM |
Wth, is there some toxic financing? How do | cj 13 | investorshub | 06/07/2016 5:41:25 PM |
Imo another 3 days plus of green. | cj 13 | investorshub | 06/06/2016 10:29:18 PM |
Very weird. That $5.73 high was shortly | hweb2 | investorshub | 06/06/2016 8:44:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Command Security Corporation Company Name:
MOC Stock Symbol:
NYSE Market:
Command Security Corporation Website:
Initiation of Phase II clinical trial of OATD-01 (KITE) for the treatment of pulmonary sarcoidosis following approval from the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). World's first administration of a chitotriosidase 1...
- OATD-01 is an innovative, first-in-class chitinase inhibitor for the treatment of sarcoidosis among other diseases where chronic inflammation leads to tissue remodeling and fibrosis - In the phase II clinical trial (KITE study), patients will take a daily oral dose of 25 mg OATD-01 or...
MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces part of the results of the work program consisting of eight drill holes for a total of 2,484 meters on the Gaboury project . Highlig...